Neural Stem Cell-conditioned Medium Protected Against Cognitive Dysfunction in APP/PS1 Mice
Molecular Neurobiology · 2026
DOI: 10.1007/s12035-025-05282-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2026. Verfasst von Xiaoyu Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical-Care Medicine, Shandong Provincial Hospital, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Neural Stem Cells, Amyloid beta-Protein Precursor, Presenilin-1. Die Arbeit nennt 65 Literaturangaben.
Abstract (Originalsprache)
More and more evidence suggested neural stem cell conditioned medium (NSC-CM) exhibited a protective effect on regenerative medicine. Our previous studies suggested that NSC-CM ameliorated Aβ2-35-induced SH-SY5Y cell apoptosis as the cell model of Alzheimer's disease (AD). Thus, we hypothesized that NSC-CM had the capacity of neuro-protecting against cognitive dysfunction in APP/PS1 mice. Male APP/PS1 mice aged 6 months as the animal model of AD were randomly assigned into two groups: the control group and NSC-CM treated group. A 100 μl NSC-CM or PBS (phosphate-buffered saline) was administered slowly by tail vein once a day for consecutive 7 days or 14 days. The new object recognition test (NORT) and open field test (OFT) were applied to test cognition and emotion. The levels of phosphorylated tau (p-Tau), NOD-like receptor family pyrin domain-containing 3 (NLRP3), caspase-1, and interleukin 1β (IL-1β) were measured by Western blot. The load of amyloid-β (Aβ) plaque was measured by thioflavin S staining while the expression of astrocytes was observed by immunofluorescence staining. NSC-CM not only significantly ameliorated cognitive and emotional dysfunctions of APP/PS1 transgenic mice but also reduced the Aβ plaque load as well as the level of p-Tau, accompanied by increased astrocyte phagocytosis and inhibiting the inflammatory activation of astrocytes as well as the levels of NLRP3, caspase-1, and IL-1β. NSC-CM might be the alternative and promising therapeutic intervention for treating AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical-Care Medicine, Shandong Provincial Hospital, Shandong University, Jinan, China.
- Department of Critical-Care Medicine, Gaotang County People's Hospital, Liaocheng, China.
- Department of Critical-Care Medicine, Shandong Province Hospital Affiliated to Shandong First Medical University, Shandong First Medical University, Jinan, China.
- Department of Psychiatry, College of Medicine, The Psychiatric Institute, University of Illinois at Chicago, 1601 West Taylor Street, Chicago, IL, 60612, USA.
- Department of Critical-Care Medicine, Shandong Provincial Hospital, Shandong University, Jinan, China. 7216263@163.com.
- Department of Critical-Care Medicine, Shandong Province Hospital Affiliated to Shandong First Medical University, Shandong First Medical University, Jinan, China. 7216263@163.com.
Zitieren
APA
Zheng, X., Xiang, Q., Dong, X., Shen, Y., Qu, T., Fang, W., & Yang, H. (2026). Neural Stem Cell-conditioned Medium Protected Against Cognitive Dysfunction in APP/PS1 Mice. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05282-w
Vancouver
Zheng X, Xiang Q, Dong X, Shen Y, Qu T, Fang W, et al. Neural Stem Cell-conditioned Medium Protected Against Cognitive Dysfunction in APP/PS1 Mice. Molecular Neurobiology. 2026. doi:10.1007/s12035-025-05282-w
BibTeX
@article{Zheng2026,
author = {Zheng, Xiaoyu and Xiang, Qian and Dong, Xiaoxu and Shen, Yang and Qu, Tingyu and Fang, Wei and Yang, Hongna},
title = {Neural Stem Cell-conditioned Medium Protected Against Cognitive Dysfunction in APP/PS1 Mice},
journal = {Molecular Neurobiology},
year = {2026},
doi = {10.1007/s12035-025-05282-w}
}
EUVIMED